Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2005
11/30/2005CN1229351C Heterocyclic compounds and methods to treat cardiac failure and other disorders
11/30/2005CN1229343C Chemotactic factor receptor active regulator
11/30/2005CN1229335C Nervinolin derivatives
11/30/2005CN1229137C New therapeutic uses of SMR1 peptides
11/30/2005CN1229133C Medicine for treating virus hepatitis and its preparing method
11/30/2005CN1229128C Detoxification tea of white bamboo
11/30/2005CN1229115C Nutritional formulation containing prebiotic substances
11/30/2005CN1229111C Sustained release preparations
11/29/2005US6969728 Antiinflammatory agents
11/29/2005US6969727 Obesity; osteoporosis
11/29/2005US6969717 Azaindole kinase inhibitors
11/29/2005US6969713 Piperidine and piperazine acetamide derivatives
11/29/2005US6969513 administering a live attenuated bacterial vector vaccine to a patient, wherein the vaccine containing an isolated cell comprising an expression vector, contains a nucleotide sequence encoding a restricted-copy-number origin of replication cassette
11/29/2005US6969508 Buccal aerosol sprays or capsules using polar and non-polar solvent which provide biologically active compounds for rapid absorption through the oral mucosa, resulting in fast onset of effect
11/29/2005CA2500217C Crystal forms of azithromycin
11/29/2005CA2288445C 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives
11/29/2005CA2099213C 4-iminoquinolines, processes for their preparation, and their use
11/29/2005CA2081068C Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of .alpha.-d-neuraminic acid
11/29/2005CA2080545C Salts of hydrazones
11/24/2005WO2005111221A1 Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine
11/24/2005WO2005111208A1 Method of proliferating plasma cell
11/24/2005WO2005111196A1 Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates
11/24/2005WO2005111055A1 Novel antibiotic kigamicins and use thereof
11/24/2005WO2005111044A1 4-substituted-1,5-dihydro-pyrido[3,2-b]indol-2-ones
11/24/2005WO2005111015A1 Substituted pyrrolidine derivative
11/24/2005WO2005111001A1 Novel fused heterocycles and uses thereof
11/24/2005WO2005110487A2 Camptothecin derivatives conjugated in position 20 with integrin antagonists
11/24/2005WO2005110486A2 7-t-butoxyiminomethylcamptothecin conjugated in position 20 with integrin antagonists
11/24/2005WO2005110450A1 Medicinal composition and therapeutic method
11/24/2005WO2005110443A1 Antiviral agent
11/24/2005WO2005110427A1 Stable oral pharmaceutical preparation comprising fosfomycin, which is intended for diabetic patients
11/24/2005WO2005034971A3 Antiviral agent
11/24/2005WO2004103271A3 Disease prevention and vaccination prior to thymic reactivations
11/24/2005US20050261584 Devices and methodologies useful in body aesthetics
11/24/2005US20050261364 Stereoisomeric form and a second antiretroviral compound; treating multidrug resistant HIV infections; protein plasma binding of the protease inhibitor has minimal or no effect on its potency; effective over a broad range of HIV mutants, bioavailability
11/24/2005US20050261336 e.g. 8-hydroxy-2-[2-[3,4-dihydroxy-5-methoxyphenyl)ethenyl]]-7-quinoline carboxylic acid; HIV integrase inhibitors; AIDS, retroviral pathologies
11/24/2005US20050261330 Derivatives of 2,2,4-trisubstituted tetrahydrofuran an antifungal agents
11/24/2005US20050261317 Inhibitors of human phosphatidylinositol 3-kinase delta
11/24/2005US20050261293 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/24/2005US20050261271 Dipeptidyl peptidase inhibitors
11/24/2005US20050261270 Modified beta-lactamases and uses thereof
11/24/2005US20050261269 New derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
11/24/2005US20050261267 Pharmaceutical formulation
11/24/2005US20050261235 2' ,5' -Oligoadenylate analogs
11/24/2005US20050261177 Compound
11/24/2005US20050261173 Antifungal parenteral products
11/24/2005US20050261165 compounds that inhibit activity of the AcrAB or AcrAB-like efflux pump are identified as compounds which reduce antibiotic resistance in a microbe that has 2 chromosomal mutations in a gene encoding an antibiotic target that renders it resistant and increased expression of at least one efflux pump
11/24/2005US20050261163 Pharmaceutical products, preparation and uses thereof
11/24/2005US20050260767 Treatment with cytokines
11/24/2005US20050260732 Polypeptide crystal having a polyhistidine tag added to the C-terminal end; effectors; drug screening for enzyme inhibitors; multiple sclerosis, diabetes, Grave's disease, rheumatic arthritis, AIDS, cancer, immunomodulators
11/24/2005US20050260601 Recombinant mutants of rhabdovirus and methods of use thereof
11/24/2005US20050260581 Gonococcal proteins and nucleic acids
11/24/2005US20050260565 contacting in vitro a sample comprising chemokine 88C receptor with a putative ligand, detecting binding of the 88C receptor and the putative ligand; increase in 88C signal transduction activity indicates the ligand is an activator, a decreasein transduction activity indicates the ligand is an inhibitor
11/24/2005US20050260560 Administering antigens capable of causing specific immune reaction(s) directed against an infectious agent and/or cells infected with the infectious agent, and decreasing a different specific immune reaction direct towards the infectious agent, infected cells and/or uninfected cells; immunotherapy
11/24/2005US20050260228 Vaccines absorbable by the transmucosal way
11/24/2005US20050260227 Novel therapeutic processes for treating cancer with specific antigens
11/24/2005US20050260226 Novel therapeutic processes for treating infectious agents by training or adoptive transfer of immune cells, and useful compositions therefor
11/24/2005US20050260223 Salmonella vaccine materials and methods
11/24/2005US20050260220 first component is the modified antigenic ectodomain of measles virus hemagglutinin protein, second component fused to first component that binds a surface protein of human immunodeficiency virus; for treating HIV infection and other therapeutic targets against which it is difficult to develop vaccines
11/24/2005US20050260211 Drug delivery; delivering a non-cytotoxic therapeutic moiety into nerve cells; nerve growth factor
11/24/2005US20050260183 Treatment of surfaces populated by bacteria with a lucilia sericata extract
11/24/2005US20050260171 Compositions containing bacteriophages and method of using bacteriophages to treat infections
11/24/2005US20050260126 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein
11/24/2005CA2567212A1 Skin cleaning composition containing long-chain alkyl polyamine
11/24/2005CA2566877A1 Medicinal composition and therapeutic method
11/24/2005CA2566703A1 Methods of inhibiting proinflammatory cytokine expression using ghrelin
11/24/2005CA2565247A1 Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates
11/24/2005CA2564934A1 Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine
11/24/2005CA2563601A1 Combinations of substituted 1-phenyl-1,5-dihydro-pyrido- [3,2-b] indol-2-ones and other hiv inhibitors
11/24/2005CA2562572A1 Camptothecin derivatives conjugated in position 20 with integrin antagonists
11/24/2005CA2562569A1 7-t-butoxyiminomethylcamptothecin conjugated in position 20 with integrin antagonists
11/23/2005EP1598368A1 Anti-pci neutralizing antibody
11/23/2005EP1598362A2 Chlamidya trachomatis antigens
11/23/2005EP1598076A1 Interleukin 6 production inhibitor
11/23/2005EP1598067A1 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors
11/23/2005EP1597376A2 Chicken rna polymerisate i promoter and the use thereof
11/23/2005EP1597350A2 Nucleic acid molecules, polypeptides, antibodies and compositions containing same useful for treating and detecting influenza virus infection
11/23/2005EP1597280A2 Monoclonal antibody production by ebv transformation of b cells
11/23/2005EP1597263A1 Preparation of a trans-calanolide ketone intermediate and chiral separation of calanolide alcohols to give racemic calanolide a
11/23/2005EP1597258A2 Novel purine derivatives, preparation method thereof, application of same as medicaments, pharmaceutical compositions and novel use
11/23/2005EP1597246A2 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
11/23/2005EP1597238A1 Hiv replication inhibiting pyrimidines and triazines
11/23/2005EP1597237A1 Pyrimidine derivatives for the prevention of hiv infection
11/23/2005EP1597236A1 Growth promotion method
11/23/2005EP1597235A1 Non-nucleoside reverse transcriptase inhibitors
11/23/2005EP1596883A1 Interferon drug therapy for the treatment of viral diseases and liver fibrosis
11/23/2005EP1596861A1 Pharmaceutical combinations comprising a nos inhibitor and an nmda receptor antagonist
11/23/2005EP1596860A2 Novel compounds
11/23/2005EP1596859A1 Treatment of diseases caused by ljungan virus by using pleconaril
11/23/2005EP1596851A1 The use of sodium 2-mercaptoethanesulfonate as antiviral agent
11/23/2005EP1596846A2 Inhibitors of hepatitis c virus, compositions and treatments using the same
11/23/2005EP1383872B1 Genetically modified yt cell line and use thereof
11/23/2005EP1381628B1 Inflammation-specific peptides and the uses thereof
11/23/2005EP1335898B1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors
11/23/2005EP1284983B1 Method used for transforming the carbonyl function in position 4'' of a cladinose unit of an aza macrolide into an amine derivative
11/23/2005EP1280777B1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
11/23/2005EP1226264B1 Cell lines and constructs useful in production of e1-deleted adenoviruses in absence of replication competent adenovirus
11/23/2005EP1183034B1 Modulators of methylation for control of bacterial virulence
11/23/2005EP1117767B1 Immunomodulation by genetic modification of dendritic cells and b-cells
11/23/2005EP1058547B1 Pharmaceutical compositions containing the phospholipase inhibitor sodium 3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-phenylmethyl)-1h-indol-4-yl]oxy]acetate
1 ... 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 ... 1798